MX2024001873A - Metodo para tratar la endometriosis y proporcionar una anticoncepcion eficaz. - Google Patents
Metodo para tratar la endometriosis y proporcionar una anticoncepcion eficaz.Info
- Publication number
- MX2024001873A MX2024001873A MX2024001873A MX2024001873A MX2024001873A MX 2024001873 A MX2024001873 A MX 2024001873A MX 2024001873 A MX2024001873 A MX 2024001873A MX 2024001873 A MX2024001873 A MX 2024001873A MX 2024001873 A MX2024001873 A MX 2024001873A
- Authority
- MX
- Mexico
- Prior art keywords
- drospirenone
- treating endometriosis
- providing effective
- effective contraception
- endometriosis
- Prior art date
Links
- 201000009273 Endometriosis Diseases 0.000 title abstract 3
- METQSPRSQINEEU-UHFFFAOYSA-N dihydrospirorenone Natural products CC12CCC(C3(CCC(=O)C=C3C3CC33)C)C3C1C1CC1C21CCC(=O)O1 METQSPRSQINEEU-UHFFFAOYSA-N 0.000 abstract 4
- METQSPRSQINEEU-HXCATZOESA-N drospirenone Chemical compound C([C@]12[C@H]3C[C@H]3[C@H]3[C@H]4[C@@H]([C@]5(CCC(=O)C=C5[C@@H]5C[C@@H]54)C)CC[C@@]31C)CC(=O)O2 METQSPRSQINEEU-HXCATZOESA-N 0.000 abstract 4
- 229960004845 drospirenone Drugs 0.000 abstract 4
- 230000002051 biphasic effect Effects 0.000 abstract 3
- 201000000736 Amenorrhea Diseases 0.000 abstract 1
- 206010001928 Amenorrhoea Diseases 0.000 abstract 1
- 208000005171 Dysmenorrhea Diseases 0.000 abstract 1
- 206010013935 Dysmenorrhoea Diseases 0.000 abstract 1
- 208000000450 Pelvic Pain Diseases 0.000 abstract 1
- 231100000540 amenorrhea Toxicity 0.000 abstract 1
- 239000003433 contraceptive agent Substances 0.000 abstract 1
- 230000002254 contraceptive effect Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención se refiere a la drospirenona para su uso en un método para tratar la endometriosis, el dolor pélvico asociado a endometriosis (DPAE) y/o la dismenorrea, que comprende administrar drospirenona en un régimen bifásico. La presente invención se refiere además al uso de drospirenona administrada en un régimen bifásico de este tipo como anticonceptivo y para inducir amenorrea, así como a una composición farmacéutica y a un kit que comprenden drospirenona administrada en un régimen bifásico de este tipo.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21382757.9A EP4134082A1 (en) | 2021-08-12 | 2021-08-12 | Method for treating endometriosis and providing effective contraception |
| PCT/EP2022/072511 WO2023017109A1 (en) | 2021-08-12 | 2022-08-11 | Method for treating endometriosis and providing effective contraception |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2024001873A true MX2024001873A (es) | 2024-03-01 |
Family
ID=77358188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2024001873A MX2024001873A (es) | 2021-08-12 | 2022-08-11 | Metodo para tratar la endometriosis y proporcionar una anticoncepcion eficaz. |
Country Status (15)
| Country | Link |
|---|---|
| EP (2) | EP4134082A1 (es) |
| JP (1) | JP2024529084A (es) |
| KR (1) | KR20240047421A (es) |
| CN (1) | CN118076358A (es) |
| AR (1) | AR126766A1 (es) |
| AU (1) | AU2022327756A1 (es) |
| CA (1) | CA3228483A1 (es) |
| CO (1) | CO2024001947A2 (es) |
| DO (1) | DOP2024000021A (es) |
| EC (1) | ECSP24016885A (es) |
| IL (1) | IL310634A (es) |
| MX (1) | MX2024001873A (es) |
| PE (1) | PE20240811A1 (es) |
| TW (1) | TW202320801A (es) |
| WO (1) | WO2023017109A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024120161A (ja) * | 2023-02-23 | 2024-09-04 | エステトラ ソシエタ ア レスポンサビリタ リミタータ | 子宮内膜症に関連する疼痛を治療するための組成物 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2652761C2 (de) | 1976-11-16 | 1985-11-21 | Schering AG, 1000 Berlin und 4709 Bergkamen | 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel |
| DE19633685C1 (de) | 1996-08-12 | 1997-10-09 | Schering Ag | Verfahren zur Herstellung von Drospirenon (6beta,7beta;15 beta,16beta-Dimethyl-en-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) sowie 7alpha-(3-Hydroxy-1-propyl)-6beta,7beta;15beta, 16beta-dimethylen-5beta-androstan-3beta,5,17beta-triol (ZK 92836) und 6beta,7beta;15beta,16beta-dimethylen-5beta-hydroxy-3-oxo-17alpha-androstan-21,17-carbolacton (90965) als Zwischenprodukte des Verfahrens |
| ITMI20042338A1 (it) | 2004-12-06 | 2005-03-06 | Ind Chimica Srl | Processo per la preparazione di drospirenone |
| US10849857B2 (en) * | 2010-07-28 | 2020-12-01 | Laboratorios Leon Farma Sa | Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same |
| AR081670A1 (es) | 2010-06-29 | 2012-10-10 | Leon Farma Sa Lab | Composicion farmaceutica que comprende drospirenona y kit anticonceptivo |
| HRP20240121T8 (hr) | 2015-06-23 | 2024-05-10 | Laboratorios Leon Farma Sa | Kontracepcija na bazi drospirenona za pacijenticu s viškom tjelesne težine |
| CA3178291A1 (en) * | 2016-08-05 | 2018-04-12 | Estetra Srl | Method for the management of dysmenorrhea and menstrual pain |
| JP2018083806A (ja) * | 2016-11-11 | 2018-05-31 | 持田製薬株式会社 | 月経困難症治療用組成物 |
-
2021
- 2021-08-12 EP EP21382757.9A patent/EP4134082A1/en not_active Withdrawn
-
2022
- 2022-08-11 IL IL310634A patent/IL310634A/en unknown
- 2022-08-11 MX MX2024001873A patent/MX2024001873A/es unknown
- 2022-08-11 TW TW111130168A patent/TW202320801A/zh unknown
- 2022-08-11 AR ARP220102164A patent/AR126766A1/es unknown
- 2022-08-11 WO PCT/EP2022/072511 patent/WO2023017109A1/en active Application Filing
- 2022-08-11 JP JP2024507980A patent/JP2024529084A/ja active Pending
- 2022-08-11 CA CA3228483A patent/CA3228483A1/en active Pending
- 2022-08-11 KR KR1020247008289A patent/KR20240047421A/ko unknown
- 2022-08-11 AU AU2022327756A patent/AU2022327756A1/en active Pending
- 2022-08-11 CN CN202280066560.XA patent/CN118076358A/zh active Pending
- 2022-08-11 PE PE2024000240A patent/PE20240811A1/es unknown
- 2022-08-11 EP EP22764717.9A patent/EP4384184A1/en active Pending
-
2024
- 2024-02-06 DO DO2024000021A patent/DOP2024000021A/es unknown
- 2024-02-22 CO CONC2024/0001947A patent/CO2024001947A2/es unknown
- 2024-03-04 EC ECSENADI202416885A patent/ECSP24016885A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW202320801A (zh) | 2023-06-01 |
| AU2022327756A1 (en) | 2024-03-14 |
| IL310634A (en) | 2024-04-01 |
| PE20240811A1 (es) | 2024-04-18 |
| WO2023017109A1 (en) | 2023-02-16 |
| EP4384184A1 (en) | 2024-06-19 |
| JP2024529084A (ja) | 2024-08-01 |
| CO2024001947A2 (es) | 2024-03-07 |
| EP4134082A1 (en) | 2023-02-15 |
| KR20240047421A (ko) | 2024-04-12 |
| CA3228483A1 (en) | 2024-02-07 |
| CN118076358A (zh) | 2024-05-24 |
| DOP2024000021A (es) | 2024-05-15 |
| AR126766A1 (es) | 2023-11-08 |
| ECSP24016885A (es) | 2024-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200900491A1 (ru) | Применение эстрадиола валерата или 17в-эстрадиола в комбинации с диеногестом для перорального лечения для поддержания и/или повышения полового влечения у особи женского пола | |
| CA2468748A1 (en) | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology | |
| ES2693085T1 (es) | Uso de estriol en bajas dosis | |
| DOP2024000021A (es) | Método para tratar la endometriosis y proporcionar una anticoncepción eficaz | |
| AR049112A1 (es) | Composiciones, metodos y kit, para el tratamiento de trastorno disforico premenstrual | |
| NZ592039A (en) | Combination therapy for the treatment of ocular neovascular disorders | |
| GEP20227407B (en) | Contraceptive composition with reduced cardiovascular effects | |
| TW200514560A (en) | Pharmaceutical formulation for contraception and hormone-replacement therapy | |
| Pietrzak et al. | Oral and transdermal hormonal contraception in women after kidney transplantation | |
| HUP0402389A2 (hu) | Ritmusszabályozó hatóanyagokat tartalmazó gyógyszerkészítmények és alkalmazásuk medencetáji fájdalmak kezelésére | |
| HUP9904344A2 (hu) | Egyfázisú fogamzásgátló eljárás és progesztin és ösztrogén kombinációját tartalmazó kit | |
| HRP20030387A2 (en) | Use of antiprogestins for prophylaxis and treatment of hormone dependent diseases | |
| HUP0401634A2 (hu) | LHRH-antagonisták használata kasztrációt nem okozó dózisokban a T-sejtes immunitás javítására és gyógyszerkészítmények előállítására | |
| MX2023002159A (es) | Composiciones y metodos para el tratamiento de la colangitis biliar primaria. | |
| CR6627A (es) | Nuevo medicamento contraceptivo y su modo de preparacion | |
| MX2021011250A (es) | Metodos y composiciones terapeuticas para tratar linfoma usando acido 6,8-bis-benciltio-octanoico. | |
| WO2020139163A3 (ru) | Комбинация противовирусных средств | |
| MX2007009061A (es) | Preparacion farmaceutica para la anticoncepcion oral. | |
| MX2024001230A (es) | Anticoncepcion oral con progestageno solo. | |
| Shavakhabov et al. | EFFICACY AND SAFETY OF CLOMIPRAMINE HYDROCHLORIDE CONTAINING NASAL SPRAY FOR THE PHARMACOTHERAPY OF PREMATURE EJACULATION. | |
| MX2020011523A (es) | Composicion farmaceutica adecuada para administracion vaginal en forma de ovulos y uso de la misma. | |
| MXPA05003364A (es) | Parche transdermico de 17(-estradiol/levonorgestrel para hormonoterapia restitutiva. | |
| A Garside et al. | An update on developments in female hormonal contraception | |
| WO2023152682A9 (en) | Contraceptive methods with scheduled bleeding effects | |
| MX2021010221A (es) | Poblaciones mejoradas de celulas germinales para terapia alogenica. |